Back to Agenda
Session 7: Summary - Cost-Benefit Analysis
Session Chair(s)
Session Chair Invited, BSN, DDS
Manager, DIA, Switzerland
This closing session will be a culmination of the two day discussion on central audit methods for site image interpretation in clinical trials. A panel, comprising of the Sessions Chairs, will present the outcomes from the discussions held within their sessions, provide a framework for the central audit method recommendation, and close with a final discussion on the importance of evaluating the many factors involved in making the decision to implement central audit method practices.
Speaker(s)
Annette Schmid, PhD
Senior Director Scientific & Medical Services, Head of Oncology Imaging Strategy, PAREXEL International, United States
Panelists
David I. Raunig
Senior Vice President, Medical & Scientific Affairs, ICON, United States
Susanta Sarkar
President, Cadenzamed LLC, United States
Andrea Perrone, MD
Head of Clinical Imaging, Translational Medicine, Merck, United States
Steven Sun, PhD
Director, Janssen R&D, United States
Have an account?
